Altamira Therapeutics (STU:2QA) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Altamira Therapeutics Days Payable?

Altamira Therapeutics's average Accounts Payable for the six months ended in Dec. 2023 was €1.23 Mil. Altamira Therapeutics's Cost of Goods Sold for the six months ended in Dec. 2023 was €0.00 Mil.

The historical rank and industry rank for Altamira Therapeutics's Days Payable or its related term are showing as below:

STU:2QA' s Days Payable Range Over the Past 10 Years
Min: 359.83 Med: 849.43 Max: 4009.33
Current: 4009.33

During the past 13 years, Altamira Therapeutics's highest Days Payable was 4009.33. The lowest was 359.83. And the median was 849.43.

STU:2QA's Days Payable is ranked better than
92.44% of 714 companies
in the Biotechnology industry
Industry Median: 146.16 vs STU:2QA: 4009.33

Altamira Therapeutics's Days Payable stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

Altamira Therapeutics Days Payable Historical Data

The historical data trend for Altamira Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Altamira Therapeutics Days Payable Chart

Altamira Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

355.32

1,303.62

Altamira Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															207.41	509.29	-	2,864.75	-

Competitive Comparison of Altamira Therapeutics's Days Payable

For the Biotechnology subindustry, Altamira Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Altamira Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Altamira Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Altamira Therapeutics's Days Payable falls into.

Altamira Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Altamira Therapeutics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (4.831	+	0.438)	/	2 )	/	0	*	365
=	2.6345					/	0	*	365
=	N/A

Altamira Therapeutics's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (2.013	+	0.438)	/	2 )	/	0	*	365 / 2
=	1.2255					/	0	*	365 / 2
=	N/A

Altamira Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Altamira Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Altamira Therapeutics (STU:2QA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Altamira Therapeutics Ltd (STU:2QA) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

CYTO:USA

Address

2 Church Street, Clarendon House, Hamilton, BMU, HM11

Website

https://www.altamiratherapeutics.com

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.

Altamira Therapeutics (STU:2QA) Headlines

No Headlines